参考文献/References:
[1].GBD 2021 US Burden of Disease Collaborators. The burden of diseases,injuries,and risk factors by state in the USA,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet,2024,404(10469):2314-2340.
[2].Escudero-Martínez I,Morales-Caba L,Segura T. Atrial fibrillation and stroke:a review and new insights [J]. Trends Cardiovasc Med,2023,33(1):23-29.
[3].Putaala J,Teppo K,Halminen O,et al. Ischemic stroke temporally associated with new-onset atrial fibrillation:a population-based registry-linkage study[J].?Stroke,2024,55(1):122-130.
[4].van Gelder IC,Rienstra M,Bunting KV,et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)[J].?Eur Heart J,2024,45(36):3314-3414.
[5].Yang Y,Wang Z,Chen Z,et al. Current status and etiology of valvular heart disease in China:a population-based survey[J]. BMC Cardiovasc Disord,2021,21(1):339.
[6].刘广志,胡荣,彭丹涛. 心源性卒中诊断中国专家共识（2020）[J]. 心肺血管病杂志,2024,43(7):669-679.
[7].Dangas GD,Weitz JI,Giustino G,et al. Prosthetic heart valve thrombosis[J]. J Am Coll Cardiol[J]. 2016,68(24):2670-2689.
[8].心肌病抗凝治疗中国专家共识专家组. 心肌病抗凝治疗中国专家共识[J]. 中国循环杂志,2021,36(12):1148-1157.
[9].吴昊晟,汤日波. 扩张型心肌病合并左心室血栓的研究进展[J]. 心肺血管病杂志,2023,42(1):84-87.
[10].阮海燕,李丽英,张木馨,等. 中国肥厚型心肌病患者血栓栓塞事件风险预测模型的构建研究[J]. 中国全科医学,2023,26(8):917-926.
[11].陈学甫,张新鑫,司金萍,等. 左心室血栓诊治研究进展[J]. 中华实用诊断与治疗杂志,2024,38(3):299-303.
[12].Krahn AD,Wilde AAM,Calkins H,et al. Arrhythmogenic right ventricular cardiomyopathy[J]. JACC Clin Electrophysiol,2022,8(4):533-553.
[13].Rao SV,O’Donoghue ML,Ruel M,et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes:a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. J Am Coll Cardiol,2025,151(13):e771-e862.
[14].Camaj A,Fuster V,Giustino G,et al. Left ventricular thrombus following acute myocardial infarction:JACC state-of-the-art review[J]. J Am Coll Cardiol,2022,79(10):1010-1022.
[15].宋岳涵,张小琼,孙雪. 急性心肌梗死患者并发急性脑梗死的危险因素及列线图预测模型构建[J]. 岭南心血管病杂志,2025,31(1):7-12,20.
[16].Kildahl HA,Brenne EL,Dalen H,et al. Systemic embolization in infective endocarditis[J]. Indian J Thorac Cardiovasc Surg,2024,40(suppl 1):40-46.
[17].张奇梁,朱一林,曹泽辉,等. 感染性心内膜炎外科治疗的研究进展[J]. 心肺血管病杂志,2024,43(5):537-539.
[18].Sambola A,Lozano-Torres J,Boersma E,et al. Predictors of embolism and death in left-sided infective endocarditis:the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry[J].?Eur Heart J,2023,44(43):4566-4575.
[19].Yesilot Barlas N,Putaala J,Waje-Andreassen U,et al. Etiology of first-ever ischaemic stroke in European young adults:the 15 cities young stroke study[J].?Eur J Neurol,2013,20(11):1431-1439.
[20].丁富霞,孙守刚. 卵圆孔未闭患者发生神经系统合并症的相关分析[J]. 中国循证心血管医学杂志,2025,17(1):59-63,67.
[21].辛宜静,杨艳敏. 卵圆孔未闭相关心源性卒中的研究进展[J]. 中华心律失常学杂志,2024,28(1):64-68.
[22].Ioannidis SG,Mitsias PD. Patent foramen ovale in cryptogenic ischemic stroke:direct cause,risk factor,or incidental finding?[J].?Front Neurol,2020,11:567.
[23].Qiao ML,Ma L,Wang CB,et al. Clinical features,risk factors and survival in cardiac myxoma-related ischemic stroke:a multicenter case-control study[J]. J Neurol Sci,2023,444:120517.
[24].Oktaviono YH,Saputra PBT,Arnindita JN,et al. Clinical characteristics and surgical outcomes of cardiac myxoma:a meta-analysis of worldwide experience[J]. Eur J Surg Oncol,2024,50(2):107940.
[25].Ma L,Cai B,Qiao ML,et al. Risk factors assessment and a Bayesian network model for predicting ischemic stroke in patients with cardiac myxoma[J].?Front Cardiovasc Med,2023,10:1128022.
[26].中国卒中学会,《中国卒中学会急性缺血性卒中再灌注治疗指南2024》编写组. 中国卒中学会急性缺血性卒中再灌注治疗指南2024[J].中国卒中杂志,2024,19(12):1460-1478.
[27].Wardlaw JM,Murray V,Berge E,et al. Recombinant tissue plasminogen activator for acute ischaemic stroke:an updated systematic review and meta-analysis[J]. Lancet,2012,379(9834):2364-2372.
[28].Menon BK,Singh N,Sylaja PN. Tenecteplase use in patients with acute ischaemic stroke[J]. Lancet,2023,401(10377):618-619.
[29].中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性卒中诊治指南2023[J]. 中华神经科杂志,2024,57(6):523-559.
[30].Liu W,Ye G,Xie S,et al. Meta-analysis of the efficacy and safety of combined arterial and venous thrombolysis in the treatment of acute ischemic stroke[J]. Neurol Res,2025,47(6):444-456.
[31].中国卒中学会,中国卒中学会神经介入分会,中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2023[J]. 中国卒中杂志,2023,18(6):684-711.
[32].Zi W,Qiu Z,Li F,et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke:the DEVT randomized clinical trial[J]. JAMA,2021,325(3):234-243.
[33].Ishfaq MF,Gulraiz S,Huang W,et al. Endovascular thrombectomy with or without intravenous thrombolysis:a meta-analysis of randomized controlled trials[J]. Interv Neuroradiol,2023,29(2):157-164.
[34].Silverio A,di Maio M,Prota C,et al. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation:systematic review and meta-analysis of 22 studies and 440?281 patients[J]. Eur Heart J Cardiovasc Pharmacother,2021,7(FI1):f20-f29.
[35].van der Horst SFB,Martens ESL,den Exter PL,et al. Idarucizumab for dabigatran reversal:a systematic review and meta-analysis of indications and outcomes[J]. Thromb Res,2023,228:21-32.
[36].中国医师协会心血管内科医师分会结构性心脏病学组,苏州工业园区东方华夏心血管健康研究院. 中国经导管左心耳封堵术临床路径专家共识（2025版）[J]. 中国介入心脏病学杂志,2025,33(1):5-32.
[37].Noseworthy PA,van Houten HK,Krumholz HM,et al. Percutaneous left atrial appendage occlusion in comparison to non-vitamin K antagonist oral anticoagulant among patients with atrial fibrillation[J]. J Am Heart Assoc,2022,11(19):e027001.
[38].Gurol ME,Sposato LA. Advances in neurocardiology:focus on anticoagulation for valvular heart disease with and without atrial fibrillation[J]. Stroke,2022,53(12):3763-3768.
[39].Mentias A,Saad M,Michael M,et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair[J]. J Am Heart Assoc,2022,11(17):e026666.
[40].Eikelboom JW,Connolly SJ,Brueckmann M,et al. Dabigatran versus warfarin in patients with mechanical heart valves[J]. N Engl J Med,2013,369(13):1206-1214.
[41].Curtain JP,Jackson AM,Shen L,et al. Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF[J]. Eur J Heart Fail,2022,24(3):551-561.
[42].Hori M,Zhu J,Liang Y,et al. Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease:the COMPASS trial[J]. Eur Heart J,2022,43(37):3542-3552.
[43].Delgado V,Ajmone Marsan N,de Waha S,et al. 2023 ESC Guidelines for the management of endocarditis[J]. Eur Heart J,2023,44(39),3948-4042.
[44].Saver JL,Carroll JD,Thaler DE,et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J]. N Engl J Med,2017,377(11):1022-1032.
[45].张玉顺,蒋世良,朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志,2021,33(1):1-10.
[46].Lyon AR,López-Fernández T,Couch LS,et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA),the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [J]. Eur Heart J,2023,44(18):1621.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(12):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(12):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(12):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(12):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(12):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(12):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]安硕研,郑金刚.左心耳封堵术预防心源性卒中的进展[J].心血管病学进展,2019,(6):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
AN Shuoyan,ZHENG Jingang.Left Atrial Appendage Closure for Prevention of Cardiogenic Stroke[J].Advances in Cardiovascular Diseases,2019,(12):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]